Extracorporeal membrane oxygenation in children with oncohematological diseases-Reference-Cited by-同舟云学术

Extracorporeal membrane oxygenation in children with oncohematological diseases

Published:2024-01-23 Issue:1 Volume:23 Page:165-171
ISSN:2414-9314
Container-title:Pediatric Hematology/Oncology and Immunopathology
language:
Short-container-title:Voprosy gematologii/onkologii i immunopatologii v pediatrii

Author:

Ryadinskaya E. A.¹^ORCID,Ivanashkin A. Yu.¹^ORCID,Rybalko A. S.²^ORCID,Lazarev V. V.³^ORCID,Kryukov I. A.¹^ORCID,Pavlenko A. A.¹^ORCID,Arzin D. N.⁴^ORCID

Affiliation:

1. The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation

2. The N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation

3. The Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation; The N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation

4. Children's Republican Clinical Hospital of Ministry of Healthcare of the Republic of Tatarstan

Abstract

The development of modern technologies and an increase in the incidence of severe pediatric acute respiratory distress syndrome in children with oncohematological diseases provide some evidence for the medical society to reconsider the indications for extracorporeal membrane oxygenation in this group of patients. The literature review presents an analysis of recent studies on extracorporeal membrane oxygenation usage in children with oncohematological diseases and after hematopoietic stem cell transplantation. The reviewed studies revealed an improvement of the survival rate among such patients over the last decade.

Publisher

Fund Doctors, Innovations, Science for Children

Reference47 articles.

1. Smith M., Hare M.L. An overview of progress in childhood cancer survival. J Pediatr Oncol Nurs 2004; 21 (3): 160–4.

2. Davidoff A.M. Pediatric Oncology. Semin Pediatr Surg 2010; 19 (3): 225–33.

3. Nakata K., Ito Y., Magadi W., Bonaventure A., Stiller C.A., Katanoda K., et al. Childhood cancer incidence and survival in Japan and England: A population-based study (1993–2010). Cancer Sci 2018; 109 (2): 422–34.

4. Rumyantsev A.G. Evolution of therapy for acute lymphoblastic leukemia in children: Empirical, biological, and organizational aspects. Pediatric Hematology/Oncology and Immunopathology. 2015; 14 (1): 5–15. URL: https://www.hemoncim.com/jour/article/view/85?locale=ru_RU (In Russ.)

5. Chima R.S., Daniels R.C., Kim M.-O., Li D., Wheeler D.S., Davies S.M., Jodele S. Improved outcomes for stem cell transplant recipients requiring pediatric intensive care. Pediatr Criti Care Med 2012; 13 (6): e336–42.